Chemistry: analytical and immunological testing – Cancer
Reexamination Certificate
2006-08-25
2010-12-07
Rawlings, Stephen L (Department: 1643)
Chemistry: analytical and immunological testing
Cancer
C435S006120, C435S007100, C435S007230, C530S350000, C530S387700, C536S023500, C536S024300
Reexamination Certificate
active
07846737
ABSTRACT:
The invention relates to newly discovered nucleic acid molecules and proteins associated with cervical cancer including pre-malignant conditions such as dysplasia. Compositions, kits, and methods for detecting, characterizing, preventing, and treating human cervical cancers are provided.
REFERENCES:
patent: 2002/0086354 (2002-07-01), Holtzman et al.
patent: 2002/0169284 (2002-11-01), Ashkenazi et al.
patent: 2002/0177553 (2002-11-01), Ashkenazi et al.
patent: 2002/0192706 (2002-12-01), Ashkenazi et al.
patent: 2003/0008352 (2003-01-01), Baker et al.
patent: 2003/0008353 (2003-01-01), Baker et al.
patent: 2003/0013153 (2003-01-01), Baker et al.
patent: 2003/0049738 (2003-03-01), Baker et al.
patent: 2003/0087270 (2003-05-01), Schlegel et al.
patent: 2003/0175754 (2003-09-01), Murry et al.
patent: 2004/0023288 (2004-02-01), Ridder et al.
patent: 2004/0219579 (2004-11-01), Aziz et al.
patent: 2005/0037010 (2005-02-01), Monahan et al.
patent: 2005/0260566 (2005-11-01), Fischer et al.
patent: 2007/0172830 (2007-07-01), Ruben et al.
patent: 1167387 (2002-01-01), None
patent: 2000-32984 (2000-02-01), None
patent: WO-99/07850 (1999-02-01), None
patent: WO-99/07893 (1999-02-01), None
patent: WO-99/35158 (1999-07-01), None
patent: WO-99/46281 (1999-09-01), None
patent: WO-99/58660 (1999-11-01), None
patent: WO-00/53756 (2000-09-01), None
patent: WO-01/42451 (2001-06-01), None
patent: WO-01/54708 (2001-08-01), None
patent: WO-01/68848 (2001-09-01), None
patent: WO-01/87917 (2001-11-01), None
patent: WO-02/057414 (2002-07-01), None
patent: WO-02/068649 (2002-09-01), None
Li (J. Cell Biol. Feb. 21, 2000; 148 (4): 791-800).
Hadj-Rabia et al. (Gastroenterology. Nov. 2004; 127 (5): 1386-1390).
Roessler et al. (Mol. Cell. Prot. 2006; 5 (11): 2092-2101).
Roessler et al. (Clin. Can. Res. 2005; 11 (18): 6550-6557).
Zolg et al. (Mol. Cell. Prot. 2004; 3 (4): 345-354).
Rae et al. (Int. J. Cancer. 2000; 88: 726-732).
Cheng et al. (Br. J. Cancer. 2002; 86: 274-281).
Ward (Developmental Oncology 1985; 21: 91-106).
Critchfield (Disease Markers. 1999; 15: 108-111).
Sidransky (Science. 1997; 278: 1054-1058).
Tockman et al (Cancer Res. 1992; 52: 2711s-2718s).
Swisshelm et al. (Gene. 1999; 226: 285-295).
Timmons et al. (Endocrinol. 2007; 148 (3): 1278-1287).
Morita et al. (Br. J. Dermatol. 2004; 151: 328-334).
Grone et al. (Int. J. Colorectal Dis. 2007; 22: 651-659).
Leotlela et al. (Oncogene. 2007; 26: 3846-3856).
Chen et al. (Molecular & Cellular Proteomics. 2002; 1: 304-313).
Vasquez-Ortiz et al. (Arch. Med. Res. Sep.-Oct. 2005; 36 (5): 448-458).
Lee et al. (Gynecol. Oncol. Apr. 2005; 97 (1): 53-59).
Sobel et al. (Hum. Pathol. Feb. 2005; 36 (2): 162-169).
GenBank AC NP—066924, Zimmerli, S.C. et al., “Human epidermal langerhans cells express the tight junction protein claudin-1 and are present in human genetic claudin-1 deficiency (NISCH syndrome),”Exp. Dermatol., vol. 17(1):20-23 (2008) Feb. 17, 2008.
Chen Yan
Gannavarapu Manjula
Glatt Karen
Hoersch Sebastian
Kamatkar Shubhangi
Clarke Marcie B.
Laccotripe Zacharakis Maria
McCarter & English LLP
Millennium Pharmaceuticals Inc.
Rawlings Stephen L
LandOfFree
Genes, compositions, kits, and methods for identification,... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Genes, compositions, kits, and methods for identification,..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Genes, compositions, kits, and methods for identification,... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4179473